Cisen Pharmaceutical Co Ltd Class A 603367
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥13.41
- Day Range
- ¥13.45–14.58
- 52-Week Range
- ¥11.34–17.45
- Bid/Ask
- ¥14.40 / ¥14.41
- Market Cap
- ¥6.52 Bil
- Volume/Avg
- 11.4 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 14.47
- Price/Sales
- 1.51
- Dividend Yield (Trailing)
- 3.03%
- Dividend Yield (Forward)
- 3.03%
- Total Yield
- 3.03%
Company Profile
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 3,402
- Website
- http://www.lkcisen.com
Comparables
Valuation
|
Metric
|
603367
|
600594
|
300194
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.47 | — | 19.25 |
Price/Book Value | 1.12 | 1.11 | 1.31 |
Price/Sales | 1.51 | 1.20 | 2.15 |
Price/Cash Flow | 7.52 | 14.04 | 12.46 |
Price/Earnings
603367
600594
300194
Financial Strength
|
Metric
|
603367
|
600594
|
300194
|
|---|---|---|---|
Quick Ratio | 2.65 | 1.21 | 0.99 |
Current Ratio | 3.56 | 1.82 | 1.59 |
Interest Coverage | 90.13 | −3.36 | 12.64 |
Quick Ratio
603367
600594
300194
Profitability
|
Metric
|
603367
|
600594
|
300194
|
|---|---|---|---|
Return on Assets (Normalized) | 6.00% | −3.17% | 1.26% |
Return on Equity (Normalized) | 7.61% | −5.06% | 1.84% |
Return on Invested Capital (Normalized) | 6.84% | −3.17% | 1.44% |
Return on Assets
603367
600594
300194
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Gkxmnkyn | Zck | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Jpmvbwhg | Wcyqvh | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Qgvzsyzwn | Pymf | $45.9 Bil | |||
| Viatris Inc
VTRS
| Rcpzckmn | Lpmw | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Kfshbchj | Knjx | $13.2 Bil | |||
| Catalent Inc
CTLT
| Dqksrfqf | Lckky | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Kzhpkqf | Nhhwxtt | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Pxxnsvnpk | Ysfz | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Xxrccjfb | Sbnr | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Tbqzhnhm | Vqjd | $2.2 Bil |
United States